Lv3
368 积分 2023-09-03 加入
Response to Comment on: “Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations”
4个月前
已完结
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
5个月前
已完结
Letrozole: Pharmacology, toxicity and potential therapeutic effects
5个月前
已完结
Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations
9个月前
已完结
皖公网安备34019202002308
